Infective Endocarditis After Invasive Medical and Surgical Procedures by Thornhill, M.H. et al.
This is a repository copy of Infective Endocarditis After Invasive Medical and Surgical 
Procedures.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/132535/
Version: Accepted Version
Article:
Thornhill, M.H. orcid.org/0000-0003-0681-4083, Dayer, M.J. and Cahill, T.J. (2018) 
Infective Endocarditis After Invasive Medical and Surgical Procedures. Journal of the 
American College of Cardiology, 71 (24). pp. 2753-2755. ISSN 0735-1097 
https://doi.org/10.1016/j.jacc.2018.03.533
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 
(CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long 
as you credit the authors, but you can’t change the article in any way or use it commercially. More 
information and the full terms of the licence here: https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Infective endocarditis after invasive medical and surgical procedures 
 
 
Author names with degrees 
 
Martin H Thornhill, MBBS, BDS, PhD
1
, Mark J Dayer, PhD FRCP
2
, Thomas J 
Cahill, MBBS, MRCP, DPhil
3
. 
 
Author affiliations 
 
1Department of Oral and Maxillofacial Medicine, Surgery & Pathology, University of 
Sheffield School of Clinical Dentistry, Sheffield, UK; 2Department of Cardiology, 
Taunton and Somerset NHS Foundation Trust, Musgrove Park, Taunton, UK; 3Oxford 
Heart Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; 
 
Brief title (120 characters or less incl spaces) 
 
Infective endocarditis after invasive procedures 
 
Complete contact information for corresponding author 
 
Professor Martin Thornhill 
Department of Oral and Maxillofacial Medicine, Surgery & Pathology 
University of Sheffield School of Clinical Dentistry 
Sheffield 
UK 
 
Tel: +44 751-555-2925 
Email: m.thornhill@sheffield.ac.uk 
 
 
Conflict/disclosure statement for all authors 
 
None to declare 
 
Keywords 
Infective endocarditis, Invasive medical procedures, Antibiotic prophylaxis  
 
 
 
The incidence of infective endocarditis, a life-threatening disease characterized by a 
focus of infection within the heart, is rising.(1-3) It is increasingly acquired in the 
healthcare setting, with at least 25% of cases occurring after a hospital or outpatient 
medical exposure.(4) In parallel, nosocomial staphylococci have replaced oral 
streptococci as the most common causative pathogen. Despite advances in 
management, for example dedicated infective endocarditis teams, multimodality 
imaging for identification of complications, and early definitive surgery for selected 
patients, in-hospital mortality remains approximately 20%.(5-7) 
 
Given the challenges of treating infective endocarditis, disease prevention is of 
fundamental importance. Development of strategies for prophylaxis of infective 
endocarditis has been frustrated, however, by a lack of high-quality evidence on 
specific triggers for the disease.(8) The necessary precursor to formation of an 
infected vegetation is bacteremia.(9) A range of invasive procedures, for example 
dental extraction or colonoscopy, cause a subclinical, transient bacteremia.(10,11) 
From the 1950s onwards, this led to burgeoning use of antibiotic prophylaxis to 
reduce the incidence of bacteremia after dental and medical procedures. Indeed, prior 
to 2007, US and European guidelines recommended antibiotic prophylaxis before a 
wide range of invasive medical procedures (Table 1).(12,13) However, a lack of 
definitive evidence for a link between these procedures and infective endocarditis, or 
for efficacy of antibiotic prophylaxis, have led to restriction in its use to high-risk 
patients undergoing invasive dental procedures in recent US and European 
guidelines.(5,6,14)   
 
In this issue of the Journal an important study by Janszky et al reopens the debate on 
the role of invasive medical procedures as a trigger for infective endocarditis.(15) 
Using the Swedish National Patient Register, the authors analyzed the frequency of 
invasive medical or surgical procedures in the 12-week period before a diagnosis of 
infective endocarditis, in comparison to an equivalent control period one year earlier. 
This µcase-crossover¶ study is an established design for examining the effect of a 
putative transient risk factor. As each patient acts as their own control, it has the 
strength of controlling for other potential confounders which are stable over time. The 
authors identified a total of 7013 cases of infective endocarditis from 1998 to 2011 
inclusive. Dental procedures were not analyzed, as the majority are not performed in 
hospital and were not therefore captured in the dataset.  
 
The principal finding was that a long list of invasive medical procedures occurred 
more frequently in the 12-weeks preceding an infective endocarditis diagnosis than at 
other time points. Many of these procedures were among those previously 
recommended for antibiotic prophylaxis, but others were not.(12,13) Several 
procedures which are known to cause bacteremia were associated with significant 
risk: these included cytoscopy (RR 2.82, 95% CI 1.42 ± 5.61), bronchoscopy (RR 
16.00, 95% CI 2.12-120.65), chronic dialysis (RR 3.64, 95% CI 2.02 ± 6.58), and 
colonoscopy (RR 2.82, 95% CI 1.42 ± 5.61). Perhaps more surprisingly, there was 
also a significant association between relatively µVWHULOH¶LQWHUYHQWLRQVVXFKDVbone 
marrow puncture (RR 4.67, 95% CI 1.34 ± 16.24) or transfusion (RR 6.69, 95% CI 
4.43 ± 10.11).  
 
How should these data be interpreted? At face value, the implication is that virtually 
any inpatient or outpatient invasive procedure may be a trigger for subsequent 
infective endocarditis. Whilst this may be correct, some caution is required. Firstly, 
observational data cannot establish causality. Despite the authors¶ efforts to avoid 
this, it is possible that some procedures were performed as part of the investigation of 
patients already suffering from infective endocarditis, but where the diagnosis had yet 
to be established. For example, anemia is a common presenting feature of infective 
endocarditis, and might lead to a blood transfusion and a bone marrow biopsy before 
the correct diagnosis is made. Alternatively, investigations may have been performed 
in patients as part of a work-up for cardiac surgery (e.g. coronary angiography), who 
went on to develop infective endocarditis as a post-operative complication. Invasive 
procedures could also be a surrogate marker of any acute illness, which might 
increase susceptibility to infective endocarditis but not be directly causative; patient-
level data might refute these criticisms. Unfortunately, the study did not have access 
to information on the microbiology of cases: identifying flora from the oral cavity, 
gastrointestinal tract, skin etcetera, after procedures associated with these sites would 
have provided further support for their role in causing infective endocarditis. 
 
Despite these criticisms, this work is by far the largest study to address the link 
between invasive medical procedures and subsequent infective endocarditis. It is the 
highest quality data available to support an association between invasive medical 
procedures and infective endocarditis, and mirrors the findings of a recent case-
crossover study suggesting a possible increase in risk after invasive dental 
procedures.(16) Importantly, it will direct future research efforts towards clarifying 
precisely which procedures are associated with highest risk, in an unbiased manner, 
and the mechanisms of healthcare-acquired infective endocarditis. Finally, whilst this 
is not a study of the role of antibiotic prophylaxis, the authors were able to estimate a 
number needed to prevent one case of endocarditis of 476, if prophylaxis was 100% 
effective. If the breadth of procedures associated with increased risk is confirmed by 
further studies, this will raise important questions for guideline committees about the 
benefits of recommending antibiotic prophylaxis prior to some of these procedures. 
However, broadening the scope of antibiotic prophylaxis to include all of these 
procedures is unlikely to be the solution. At least for those procedures where sterility 
should be easy to achieve and maintain, the solution is more likely to lay with 
improved sterile technique, infection control procedures and identifying systematic 
approaches for reducing healthcare-associated bacteremia rather than necessarily 
advocating antibiotic prophylaxis. 
 
 
Table 1: Historical and current recommendations for use of antibiotic prophylaxis in patients undergoing invasive medical and dental 
procedures alongside risk estimates for post-procedural infective endocarditis from Janszky et al 
 
Procedure Source 
 AHA 1997 (12) ESC 2004 (13) 
Current Recommendations 
AHA 2007 (14) 
ESC 2015 (6) 
Janszky et al. 2018 (15) 
Outpatient Inpatient 
GI Procedures      
Endoscopic oesophageal procedures (including TOE) ض ض - 2.60 (1.25-5.39) 3.60 (1.34-9.70) 
Upper GI Endoscopy with/without biopsy Optional for HR - - 2.50 (1.59-3.94) 3.97 (2.68-5.88) 
Lower GI Endoscopy with/without biopsy Optional for HR - - 2.89 (1.35-6.17) 2.82 (1.42-5.61) 
ERCP (Endoscopic Retrograde Cholangio-Pancreatography) ض ض - 2.60 (1.25-5.39) 3.60 (1.34-9.70) 
GU Procedures  
 
   
Endoscopic prostate procedures ض ض - - - 
Cystoscopy and endoscopic urological procedures ض ض - 1.59 (0.98-2.58) 4.40 (1.67-11.62) 
Obstetric & Gynaecological Procedures      
Caesarian section Optional for HR If infection present - - - 
Vaginal delivery Optional for HR If infection present - - - 
Abortion/dilatation and curettage (D&C) If infection present If infection present - 1.49 (1.17-1.90) 3.00 (1.81-4.98) 
Respiratory Procedures  
 
   
Bronchoscopic procedures (esp. rigid) ض ض - 5.00 (1.10-22.82) 16.00 (2.12-120.65) 
ENT Procedures  
 
   
Tonsillectomy/adenoidectomy ض ض - 1.49 (1.17-1.90) 2.33 (0.60-9.02) 
Dental Procedures  
 
   
Dental extractions ض ض ض - - 
Dental scaling/gingival procedures ض ض ض - - 
Endodontic procedures ض ض ض - - 
 
HR ± high risk patients; ض - recommended; - not recommended 
This table includes procedures for which antibiotic prophylaxis was previously recommended by the AHA or ESC and those for whom it is currently recommended. The risk of infective 
endocarditis after other invasive procedures was evaluated by Janszky et al and is shown in their manuscript. 
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